Abstract:Objective To evaluate the mRNA expression levels of thymidylate synthase(TS), dihydropyrimidine dehydrogenase(DPD)and thymidine phosphorylase(TP)in gastric carcinoma,and to assess whether the expression levels of these enzymes have any relationship with clinicopathological fea- tures or 5-fluorouracil(5-Fu)chemosensitivity.Methods The TS/DPD/TP mRNA expression in 4 gas- tric carcinoma cell lines,tumor tissue and adjacent normal tissue of 52 patients with gastric carcinoma was detected by semi-quantitative reverse-transcription polymerase chain reaction(RT-PCR).MTT assay was used to evaluate 50% inhibitory concentration of grouch(IC50)of 5-Fu of 4 gastric cancer cell lines,and inhibitory rate of primary culture cells of 30 cases of gastric cancer.Results In 4 gastric cancer cell lines,DPD mRNA level was correlated with 5-Fu IC50(r = 0.999,P0.01),but TS or TP mRNA levels were not correlated with 5-Fu IC50(P0.05).TS and TP mRNA levels in tumor tissues were both signif- icantly higher than those in normal tissues(1.32±0.70 vs 0.93±0.48,P0.01;0.65±0.37 vs 0.51±0.33,P0.01),but there was no significant difference in DPD mRNA expression between tumor and nor- mal tissue(0.89±0.39 vs 0.93±0.47,P0.05).The expression of TS mRNA was closely correlated with the depth of invasion(P0.05),distant metastasis(P0.01)and TNM stage(P0.01),DPD mRNA tended to be highly expressed in intestinal-type gastric cancer(P0.01)or the cases of tumor surface5 cm(P0.01),and TP mRNA levels correlated significantly with depth of invasion(P0.05)and distant metastasis(P0.05).TS(r =-0.540,P0.01)and DPD mRNA(r =-0.672,P0.01)were inversely associated with 5-Fu sensitivity,respectively,but no significant association was ob- served between TP mRNA expression and 5-Fu sensitivity(r =-0.317,P0.05).Conclusion TS and TP mRNA levels of tumor tissues were both significantly higher than those of normal tissues in gastric cancer,and correlated very well with clinical stage.DPD mRNA expression was correlated significantly with Lauren pathologic classification and tumor surface,and DPD mRNA level might be a predictive index of 5- Fu chemosensitivity.

Expressions and Prognostic Values of 5-Fluorouracil Metabolic Enzymes in Gastric Carcinoma

Expressions and Prognostic Values of Dihydropyrimidine Dehydrogenase(dpd) and Thymidyeate Synthase (TS) in Colorectal Carcinoma

The Expression and Significance of Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase in Gastric Carcinoma

The Thymidine Phosphorylase to Dihydropyrimidine Dehydrogenase Rate in Gastric Cancer

Polyunsaturated Fatty Acids Augment Tumoricidal Action Of 5-Fluorouracil On Gastric Cancer Cells By Their Action On Vascular Endothelial Growth Factor, Tumor Necrosis Factor-Alpha And Lipid Metabolism Related Factors

The mRNA expression and significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase in gastric carcinoma

Expression of ToPo Ⅱ,MRP,GST-π in Gastric Carcinoma and Its Relationship with Prognosis

Correlation of Thymidylate Synthase, Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase with Sensitivity of Gastrointestinal Cancer Cells to 5-Fluorouracil and 5-Fluoro-2’-deoxyuridine

Clinicopathological and related gene analysis in gastric adenocarcinoma and their correlation with prognosis

A Clinical Study on Apoptosis and Proliferation of Gastric Adenocarcinoma Cells Induced by 5'-Deoxy-5-fluorouridine (5'-DFUR)

Tumor and Serum Gamma-Glutamyl Transpeptidase, New Prognostic and Molecular Interpretation of an Old Biomarker in Gastric Cancer

Deciphering the potential value of 5-fluorouracil metabolic enzymes in predicting prognosis and treatment response of colorectal cancer patients

Thymidylate Synthase Predicts for Clinical Outcome in Invasive Breast Cancer.

Clinicopathologic and Prognostic Significance of Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Activity in Human Colorectal Carcinoma

Correlated Analysis of 5 Fluorouracil Metabolic Enzymes with Tumor Response after SOX Regimen Neoadjuvant Chemotherapy in Advanced Gastric Cancer

Relationship Between the Fluorouracil Pathway Gene and Effect of Chemotherapy in Advanced Gastric Cancer after Surgery

DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU: results from genotyping study on 75 gastric carcinoma and colon carcinoma patients.

Correlations between serum levels of TS,TP and clinical outcome in Chinese patients with advanced gastric cancer receiving fluorouracil-based chemotherapy

Expression of TP, DPD is related with fluoropyrimidines sensitivity in colorectal cancer

Polymorphisms of Dihydropyrimidine Dehydrogenase Gene and Clinical Outcomes of Gastric Cancer Patients Treated with Fluorouracil-Based Adjuvant Chemotherapy in Chinese Population.

DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU